BackNeurocrine Biosciences Overview

Neurocrine Biosciences Current Cash

Track Neurocrine Biosciences's current cash ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$0.00
↓ 100.00% YoYΔ $-264.00M vs prior year quarter

Peer average

Loading

Neurocrine Biosciences Current Cash History

Loading

Neurocrine Biosciences vs. peers: Current Cash Comparison

Loading

Neurocrine Biosciences Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Neurocrine Biosciences (NBIX) FAQ

Neurocrine Biosciences (NBIX) currently reports a current cash of $0 as of June 2026. That compares with $260M in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Neurocrine Biosciences's current cash history and peer comparisons.

Neurocrine Biosciences's current cash decreased from $260M to $0 — a 100.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Neurocrine Biosciences reported $0 in current cash as of June 2026. That compares with $260M in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Neurocrine Biosciences, and consider following NBIX for alerts when major investors trade the stock.

Neurocrine Biosciences is classified in the Healthcare sector. On current cash, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NBIX with unrelated industries.